Holen Sie sich die Stockscreener-App
5.85
5.67%
0.29
Handel nachbörslich:
5.85
Schlusskurs vom Vortag:
$5.56
Offen:
$5.52
24-Stunden-Volumen:
98,401
Relative Volume:
0.97
Marktkapitalisierung:
$68.95M
Einnahmen:
$52.29M
Nettoeinkommen (Verlust:
$-73.52M
KGV:
-8.8636
EPS:
-0.66
Netto-Cashflow:
$-100.45M
1W Leistung:
+3.43%
1M Leistung:
+27.44%
6M Leistung:
+31.73%
1J Leistung:
-34.06%
1-Tages-Spanne:
$5.25
$5.9817
1-Wochen-Bereich:
$5.25
$5.9817
52-Wochen-Spanne:
$3.61
$9.20
Precision Biosciences Inc Stock (DTIL) Company Profile
Firmenname
Precision Biosciences Inc
Sektor
Branche
Telefon
919-314-5512
Adresse
302 EAST PETTIGREW STREET, DURHAM, NC
Vergleichen Sie DTIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
5.85 | 65.54M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Eingeleitet | Guggenheim | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-09 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Fortgesetzt | BTIG Research | Buy |
| 2020-04-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Stifel | Buy |
| 2020-02-25 | Eingeleitet | William Blair | Outperform |
| 2019-08-09 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-22 | Eingeleitet | Barclays | Overweight |
| 2019-04-22 | Eingeleitet | Goldman | Buy |
| 2019-04-22 | Eingeleitet | JP Morgan | Overweight |
| 2019-04-22 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten
Precision BioSciences announces late-breaking oral presentation for PBGENE-HBV at AASLD The Liver Meeting 2025 - MarketScreener
Precision Biosciences Announces Late-Breaking Oral Presentation For Pbgene-Hbv At Aasld The Liver Meeting® 2025 - TradingView
Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting® 2025 - Yahoo Finance
Will a bounce in Precision BioSciences Inc. offer an exitWeekly Profit Report & Community Verified Trade Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidateMarket Performance Summary & Weekly Breakout Stock Alerts - newser.com
How Precision BioSciences Inc. stock trades during market volatilityShare Buyback & Safe Entry Point Alerts - newser.com
Is Precision BioSciences Inc. reversing from oversold territoryRecession Risk & Verified Chart Pattern Trade Signals - newser.com
Is Precision BioSciences Inc. stock gaining market shareJuly 2025 Price Swings & Short-Term Swing Trade Alerts - newser.com
Has Precision BioSciences Inc. formed a bullish divergenceOil Prices & Reliable Entry Point Trade Alerts - newser.com
Can Precision BioSciences Inc. stock resist market sell offsMarket Performance Summary & Real-Time Stock Entry Alerts - newser.com
Why Precision BioSciences Inc. stock attracts high net worth investors2025 Big Picture & Safe Entry Zone Identification - newser.com
Is Precision BioSciences Inc. (PBS0) stock undervalued by metricsMarket Weekly Review & Fast Entry High Yield Stock Tips - newser.com
Precision BioSciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Key metrics from Precision BioSciences Inc.’s quarterly dataTrade Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
Is Precision BioSciences Inc. meeting your algorithmic filter criteriaQuarterly Growth Report & Community Driven Trade Alerts - newser.com
What high frequency data says about Precision BioSciences Inc.July 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com
Will Precision BioSciences Inc. stock gain from lower inflationPortfolio Value Report & Fast Moving Stock Trade Plans - newser.com
News impact scoring models applied to Precision BioSciences Inc.IPO Watch & Free Technical Pattern Based Buy Signals - newser.com
Using RSI to spot recovery in Precision BioSciences Inc.Market Movement Recap & AI Forecasted Entry and Exit Points - newser.com
Will Precision BioSciences Inc. stock recover faster than marketTrade Ideas & Weekly Hot Stock Watchlists - newser.com
What moving averages say about Precision BioSciences Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for - PharmiWeb.com
Precision BioSciences (DTIL) Showcases Genomic Advances with ARC - GuruFocus
Precision BioSciences publishes research on ARCUS gene editing platform By Investing.com - Investing.com Canada
Relative strength of Precision BioSciences Inc. in sector analysisWall Street Watch & Community Verified Swing Trade Signals - newser.com
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases - The AI Journal
Best data tools to analyze Precision BioSciences Inc. stockMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Regression analysis insights on Precision BioSciences Inc. performanceJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
Does Precision BioSciences Inc. qualify in momentum factor screeningWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
Why retail investors pile into Precision BioSciences Inc. stock2025 Market Overview & Reliable Volume Spike Alerts - newser.com
Precision BioSciences (NASDAQ:DTIL) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - BioSpace
Precision Biosciences, Inc. Announces Opening of First Clinical Trial Site in U.S. for Eliminate-B Trial - MarketScreener
Precision BioSciences (DTIL) Commences U.S. Clinical Trial for P - GuruFocus
Automated trading signals detected on Precision BioSciences Inc.July 2025 Trends & Safe Entry Zone Tips - newser.com
Can Precision BioSciences Inc. (PBS0) stock hold up in economic slowdownPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com
What momentum indicators show for Precision BioSciences Inc. stockOptions Play & Verified Swing Trading Watchlist - newser.com
Order flow analysis tools used on Precision BioSciences Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
Can a trend reversal in Precision BioSciences Inc. lead to recoveryWeekly Investment Summary & Fast Exit and Entry Strategy Plans - newser.com
Why Precision BioSciences Inc. stock is rated strong buyTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-05 04:45:59 - newser.com
Why global investors buy Precision BioSciences Inc. (PBS0) stock2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
Published on: 2025-10-03 06:51:55 - newser.com
How to integrate Precision BioSciences Inc. into portfolio analysis toolsQuarterly Risk Review & Daily Price Action Insights - newser.com
Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Precision Biosciences Inc-Aktie (DTIL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Brown Melinda | Director |
Sep 22 '25 |
Buy |
4.89 |
1,400 |
6,846 |
21,965 |
| Kelly John Alexander | Chief Financial Officer |
Jul 03 '25 |
Sale |
4.26 |
14,827 |
63,163 |
73,485 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):